Selinexor in Combination With Thalidomide and Dexamethasone in RRMM
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Methods of T Cell Depletion Trial (MoTD)
- Status
- RECRUITING
- Phase
- PHASE2
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
- Status
- RECRUITING
- Phase
- N/A
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
- Status
- TERMINATED
- Phase
- PHASE1
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ATG-010(Selinexor) in Combination With Chemotherapy in RRMM
- Status
- RECRUITING
- Phase
- PHASE2
Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression
- Status
- COMPLETED
- Phase
- NA
Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients
- Status
- COMPLETED
- Phase
- NA
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- N/A
Double Filtration Plasmapheresis Combined With Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE1
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
- Status
- COMPLETED
- Phase
- N/A
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
- Status
- TERMINATED
- Phase
- N/A
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2